A new trial involving 17,000 people on weight loss drugs found they reduced the risk of stroke and heart disease by half.

The economic impact of the problem is evident ... And there is still time; for example, the patent loss for Ozempic is expected in 2031. Later for new generations, like Mounjaro or Wegoby.

For the last few months, not a day has gone by where tariffs haven’t been on the tip of everyone’s tongue. The economic ...

These GLP-1 drugs have proven effective at helping people lose weight—and are showing promise for a host of other indications ...

Many individuals' lives have been transformed through the support of the WeightWatchers program. Here's the status of the ...

A new study into GLP-1RA drugs provides previously unknown insights into the impact this class of drugs may have on eating habits. The study was helmed by the US Department of Agricultural Economics & ...